CACNG5

Across TCGA pan-cancer cohorts, CACNG5 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated CACNG5 data layer compared with 21 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CACNG5 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated CACNG5 expression acts as an unfavorable survival marker.

LUAD, PDAC, and GBM are the cancer types where CACNG5 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.571	0.937	.001	29	view →
PDAC	DFS	Quartile	II,III,IV	0.568	0.958	.014	7	view →
GBM	DFS	Median	All	0.290	0.441	.017	3	view →
LSCC	OS	Median	II,III,IV	0.947	1.000	.045	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

CACNG5–LUAD (OS)

Open the LUAD breakdown →